Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Radiotherapy Clinical Trials

5 recruiting trials for Radiotherapy. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
5
Total Trials
5
Recruiting Now
2
Phase 3 Trials
5
Sponsors

Recruiting Trials

RECRUITINGNCT05754203

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

Investigators intend to combine low-dose hypersensitivity with high-dose immunopotentiation effect, and use super-hyperfractionation pulse radiotherapy, which is expected to...

Sponsor: Xinqiao Hospital of ChongqingEnrolling: 402 locations
RECRUITINGPhase 4NCT06903312

Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

This is Phase IV, randomized, multi arm, multicenter, low interventional clinical trial, aiming to evaluate if treatment of primary tumor in mRCC patients with initial benefit to...

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSEnrolling: 4091 location
RECRUITINGPhase 2NCT07165847

Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and...

Neoadjuvant radiotherapy plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial...

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityEnrolling: 401 location
RECRUITINGPhase 3NCT06964568

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

The goal of this clinical trial is to learn if concurrent chemoradiotherapy followed by immunotherapy as maintenance therapy works to treat locally advanced esophageal squamous...

Sponsor: Fudan UniversityEnrolling: 4521 location
RECRUITINGPhase 3NCT04453826

Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma

Through multicenter, open-label, randomised clinical trials, we intend to demonstrate that concurrent and adjuvant PD-1 treatment added to chemo-radiotherapy could further...

Sponsor: Sun Yat-sen UniversityEnrolling: 3886 locations